Diverse group of TB stakeholders share and learn about new developments in TB drug and drug susceptibility testing research

The CPTR Initiative continues to demonstrate its value and role in accelerating the development of new TB regimens and drug susceptibility testing (DST), as well as tools to help drive and focus research efforts. Various CPTR members and TB stakeholders reflect on the breadth and value of CPTR and its annual Workshop.Continue reading